Free Trial
LON:IBT

International Biotechnology (IBT) Share Price, News & Analysis

International Biotechnology logo
GBX 656.02 +8.02 (+1.24%)
As of 03:14 AM Eastern

About International Biotechnology Stock (LON:IBT)

Key Stats

Today's Range
656.02
656.02
50-Day Range
562
658
52-Week Range
480
736
Volume
609 shs
Average Volume
91,623 shs
Market Capitalization
£235.65 million
P/E Ratio
6.26
Dividend Yield
4.42%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

IBT Stock News Headlines

Critical AI announcement set to ignite AI 2.0
While the market chops sideways and headlines dominate the news cycle, a small group of traders is quietly taking advantage of a reliable volatility pattern. A veteran trader just revealed how his strategy cuts through the noise—using fast trades, clear rules, and no overnight risk.
UK firms fear tougher employment regulation, CBI says
See More Headlines

IBT Stock Analysis - Frequently Asked Questions

International Biotechnology's stock was trading at GBX 682 at the beginning of the year. Since then, IBT shares have decreased by 3.8% and is now trading at GBX 656.02.

International Biotechnology (LON:IBT) issued its quarterly earnings results on Tuesday, May, 13th. The company reported ($5.60) earnings per share for the quarter. International Biotechnology had a trailing twelve-month return on equity of 13.67% and a net margin of 90.66%.

Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that International Biotechnology investors own include Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), abrdn New India Investment Trust (ANII), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR) and Oxford Pharmascience Group (OXP).

Company Calendar

Last Earnings
5/13/2025
Today
8/07/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
LON:IBT
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 104.80
Trailing P/E Ratio
6.18
Forward P/E Ratio
686.74
P/E Growth
N/A
Net Income
£37.91 million
Net Margins
90.66%
Pretax Margin
N/A
Return on Equity
13.67%
Return on Assets
3.57%

Debt

Debt-to-Equity Ratio
8.09
Current Ratio
N/A
Quick Ratio
0.32

Sales & Book Value

Annual Sales
£41.82 million
Price / Sales
5.57
Cash Flow
GBX 4.16 per share
Price / Cash Flow
155.74
Book Value
GBX 766.24 per share
Price / Book
0.85

Miscellaneous

Outstanding Shares
35,921,299
Free Float
N/A
Market Cap
£232.77 million
Optionable
Not Optionable
Beta
0.21
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (LON:IBT) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners